Human Fibroblast Growth Factor Receptor 3b (FGFR3b) Protein

Este producto es parte de FGFR3 - fibroblast growth factor receptor 3
Product Graph
169€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Fibroblast Growth Factor Receptor 3b (FGFR3b) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx169305
tested applications
WB

Description

Human Fibroblast Growth Factor Receptor 3 (FGFR3b) Protein is a recombinant protein produced in HEK293 cells.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Fibroblast Growth Factor Receptor 3b (FGFR3b)
Host
HEK293 cells
Origin
Human
Conjugation
Unconjugated
Observed MW
Molecular Weight: Calculated MW: 41.2 kDa  Observed MW (SDS-PAGE): 55 kDa
Sequence Fragment: 23-377 AA (Isoform 2).
Tag: C-terminal 10 His tag
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Purification
Purified by affinity chromatography.
Size 1
10 µg
Size 2
50 µg
Size 3
100 µg
Form
Liquid 
Tested Applications
WB
Buffer
PBS, containing 20% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store between -20 °C and -80 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P22607-2
Alias
ACH,CEK2,JTK4,CD333,FGFR-3
Background
Protein FGFR3
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Fibroblast growth factor receptor 3 (FGFR3) FGFR3 is a transmembrane tyrosine kinase receptor that mediates fibroblast growth factor (FGF) signaling, playing critical roles in skeletal development, cartilage maintenance, and cell proliferation. Structurally, FGFR3 comprises an extracellular ligand-binding domain with three immunoglobulin-like loops, a single transmembrane domain, and an intracellular kinase domain that transduces signals upon ligand-induced dimerization and autophosphorylation. FGFR3 is highly expressed in cartilage, where it regulates chondrocyte differentiation and proliferation. Gain-of-function mutations in FGFR3 are associated with skeletal dysplasias such as achondroplasia and thanatophoric dysplasia, characterized by impaired bone growth due to excessive inhibition of chondrocyte proliferation. Additionally, FGFR3 is implicated in cancer, including bladder cancer and multiple myeloma, where aberrant activation of FGFR3 signaling promotes cell proliferation and survival. FGFR3’s regulatory roles in growth plate development and oncogenesis highlight its dual importance in development and disease pathology.

Related Products

EH3061

Human FGFR3(Fibroblast Growth Factor Receptor 3) ELISA Kit

Ver Producto
FNab10801

anti- FGFR3 antibody

Ver Producto
P1531

Recombinant Human FGFR3

Ver Producto